D
DermaSensor
Biotech & Life Sciences · Miami, United States · Founded 2009
Health technology company designing tools to better equip primary care providers for skin cancer checks MoreLess
DermaSensor is a health technology company that has developed a handheld device for the early detection of skin cancer. The device is designed to be used by primary care physicians, enabling them to conduct non-invasive assessments of skin lesions during routine check-ups.
The core technology combines optical spectroscopy and artificial intelligence. By analyzing the light reflected from a skin lesion, the device's proprietary algorithms can assess the risk of cancer in real-time. This provides immediate results to the physician, helping them to make more informed decisions about whether to refer a patient to a specialist for further investigation.
The company's business model is focused on selling these devices to healthcare providers, including individual physician offices, health systems, and walk-in clinics. By equipping primary care physicians with this tool, DermaSensor aims to improve the early detection rates of skin cancer, which can lead to better patient outcomes and lower healthcare costs.
Keywords: skin cancer, medical device, primary care, artificial intelligence, spectroscopy, non-invasive, early detection, health technology, diagnostics, dermatology
Company overview
DermaSensor company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2009
- Headquarters
- Miami, United States
- Employees
- 35
- Open positions
- None listed
- Dealroom signal
- 82.7
Valuation & funding
DermaSensor funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Oct 2025 | $16M | $64M | Kern Venture Group · Pier 70 Ventures · GenHenn Capital | ↗ |
| EARLY VCOther financing | Jun 2022 | $10M | $58M | Alberto Beeck · Maurice R. Ferre M.D. · Ernest Bachrach · Ceros capital Markets | ↗ |
| SERIES BOther financing | Dec 2021 | $8.5M | $34M | Undisclosed | — |
| SERIES BOther financing | Aug 2021 | $10M | $40M | SternAegis Ventures | — |
| SERIES AOther financing | Jun 2020 | $12M | $46M | David Matlin · SternAegis Ventures · Maurice R. Ferre M.D. | — |
| EARLY VCOther financing | Dec 2018 | Undisclosed | ↗ | ||
| ANGELOther financing | Feb 2015 | Undisclosed | — | ||
| SPINOUTOther financing | May 2009 | Boston University | — |
Growth signals
DermaSensor website traffic
Latest recorded traffic for DermaSensor is 30K monthly website visits, up 114.3% over the last three months. DermaSensor's team grew 12.9% over the past year.
Comparisons
DermaSensor compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
DermaSensor's talent
Source: Dealroom Talent Intelligence.
Investors
10 investors on DermaSensor's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where DermaSensor has talent and traffic
team presence
In the news
Latest news about DermaSensor
Recent press, funding announcements, and product moves mentioning DermaSensor — open to read from the original sources.
Market sentiment
What the market is saying about DermaSensor
An AI-synthesized read of the highest-engagement posts about DermaSensor on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See DermaSensor’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.